Recursion Pharmaceuticals (NASDAQ:RXRX) is a biotech innovator who knows what ... to make a small, strategic investment in the firm back in 2023. But just because Nvidia and Cathie Wood have ...
Chicago Partners Investment Group LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.5% in the fourth quarter, according to its most recent Form 13F filing ...
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take a drubbing. But at OSE Immunotherapeutics, which aims to prevent ...
Capital Investment Advisors LLC lifted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.0% during the fourth quarter, according to the company in its most ...
SAN FRANCISCO – Vir Biotechnology, Inc., a $1.5 billion market cap biotech company, announced a change in its executive team with the upcoming departure of Ann (Aine) M. Hanly, Ph.D., and the ...
Analyst opinions on Xencor's prospects are mixed, reflecting the inherent uncertainties in biotechnology investing. Recent InvestingPro data shows that 4 analysts have revised their earnings ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Not only that, but activist investor Carl Icahn boosted his stake in a petroleum refiner, and another biotech company also had a beneficial owner return to the buy window. Let’s take a quick ...
Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.
Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, financial disclosures show. The documents, which STAT obtained ...
Hosted on MSN11d
BIA report: UK biotech investment surged to £3.5bn in 2024The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback